<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="148016">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01946087</url>
  </required_header>
  <id_info>
    <org_study_id>4-2012-0283</org_study_id>
    <nct_id>NCT01946087</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning Induces Myocardial RISK Signaling Pathway Via High Mobility Group Box 1 Preconditioning in Patients Undergoing Valvular Heart Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>South Korea: Korea Food and Drug Administration (KFDA)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether RIPC protects the heart against I/R injury
      through recruitment of the RISK pathway in human subjects. Also, we are to investigate
      whether RIPC activates RISK pathway by exerting high mobility group box 1 (HMGB 1)
      preconditioning effect.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Assessment of the RIPC-induced activation of RISK pathway by comparison of the phosphorylation of the PI3K-Akt and Erk 1/2 at the left ventricular myocardium between the RIPC and control groups</measure>
    <time_frame>Before the CPB institution, 10 min after CPB wean-off</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessment of the RIPC-induced activation of RISK pathway at the myocardium : obtaining the 3X3mm myocardial tissue by punch needle biopsy at left ventricle by cardiac surgeon -&gt; immunoblot analysis with the use of antibody of ERK1/2, phosphorylated ERK1/2, Akt, Phosphorylated Akt.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of RIPC-induced release of HMGB1 by comparison of serum HMGB1 level by ELISA between the RIPC and control groups</measure>
    <time_frame>Before the CPB institution, 10 min after CPB wean-off</time_frame>
    <safety_issue>No</safety_issue>
    <description>Effect of RIPC on the serum HMGB1 level : Sampling of 5 mL arterial blood -&gt; measurement of serum HMGB1 using the HMGB1 ELISA kit II</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Patients Undergoing Elective Lumbar Spinal Surgery</condition>
  <arm_group>
    <arm_group_label>HMGB1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high mobility group box 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote ischemic preconditioning at left upper arm</intervention_name>
    <description>Placement of automated cuff-inflator on the left upper arm after induction of anesthesia RIPCgroup-3 cycles of 5 min ischemia (250mmHg inflation) &amp; 5 min reperfusion (deflation)</description>
    <arm_group_label>HMGB1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>keeping the cuff deflated</description>
    <arm_group_label>study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Seventy two adults scheduled for elective AVR surgery for degenerative AS

        Exclusion Criteria:

          -  Patient with diabetes taking older sulphonylureas, LV ejection fraction &lt;50%
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jae-Kwang Shim, MD</last_name>
    <phone>82-2-2228-8515</phone>
    <email>aneshim@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Kwang Shim, MD</last_name>
      <phone>82-2-2228-8515</phone>
      <email>aneshim@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 16, 2013</lastchanged_date>
  <firstreceived_date>September 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Remote ischemic preconditioning</keyword>
  <keyword>Myocardial ischemia reperfusion injury</keyword>
  <keyword>RISK pathway</keyword>
  <keyword>High mobility group box 1</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
